BioCentury
ARTICLE | Financial News

Akebia proposes IPO

February 17, 2014 8:00 AM UTC

Akebia Therapeutics Inc., Cambridge, Mass. Business: Hematology, Cardiovascular Date announced: 2/14/14 Type: IPO To be raised: Up to $75 million Shares: TBD Price: TBD Underwriters: Morgan Stanley; C...